Mayne Pharma Group Limited
MAYNF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$94 | -$174 | -$317 | -$209 |
| Dep. & Amort. | $73 | $72 | $76 | $82 |
| Deferred Tax | $0 | $0 | $50 | $63 |
| Stock-Based Comp. | $4 | $0 | $7 | $5 |
| Change in WC | $43 | $25 | $145 | -$9 |
| Other Non-Cash | -$8 | $62 | -$3 | $61 |
| Operating Cash Flow | $17 | -$15 | -$43 | -$17 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$12 | -$8 | -$220 | -$12 |
| Net Acquisitions | $0 | $7 | $842 | $5 |
| Inv. Purchases | $0 | $0 | -$128 | $0 |
| Inv. Sales/Matur. | $0 | $89 | $0 | $0 |
| Other Inv. Act. | -$56 | -$35 | -$22 | -$22 |
| Investing Cash Flow | -$68 | $53 | $473 | -$29 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$4 | -$11 | -$372 | $40 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | -$0 | -$11 | -$6 | $0 |
| Dividends Paid | $0 | $0 | -$45 | $0 |
| Other Fin. Act. | $3 | $2 | -$8 | -$12 |
| Financing Cash Flow | -$1 | -$20 | -$431 | $28 |
| Forex Effect | $1 | -$1 | -$3 | $7 |
| Net Chg. in Cash | -$50 | $17 | -$4 | -$1 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $110 | $93 | $97 | $98 |
| End Cash | $60 | $110 | $102 | $97 |
| Free Cash Flow | $5 | -$36 | -$263 | -$28 |